ROVING PEN

Abstract

& This study represents the best available long-term data on the potential value of using the RA as a bypass conduit. & It is a patient-level pooled analysis comparing RA vs SVG in adult patients undergoing isolated CABG from 5 countries (Australia, Italy, Serbia, South Korea, and the UK) with enrollment from 1997 to 2009 and follow-up completed in 2019. Patients were randomized to undergo either RA (n = 534) or saphenous vein (n = 502) grafts for CABG. & At a median follow-up of 10 years, the use of the RA, compared with the SVG, was associated with a statistically significant reduction in the incidence of the composite outcome of death, myocardial infarction (MI), or repeat revascularization and of the composite of death or MI.